Innovating Works

RENOVALIA INGENIERIA EPC

Extinguida
GLIOGUIDE: Commercialising a novel glioblastoma targeted therapy and a companion diagnostic compound TARTU ULIKOOL tramitó un H2020: ERC-2017-PoC Glioblastoma (GBM), is the most aggressive form of primary brain cancer and is diagnosed in 22,000 people per year in the EU. GBM is the mos...
2018-05-03 - 2019-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.